Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection

Jean Mukherjee, Liise Anne Pirofski, Matthew D. Scharff, Arturo Casadevall

Research output: Contribution to journalArticle

80 Scopus citations

Abstract

The fungus Cryptococcus neoformans is an important opportunistic pathogen for patients with AIDS. C. neoformans infections frequently involve the brain and are often fatal. In the setting of AIDS C. neoformans infections are incurable and new treatment strategies are urgently needed. Passive administration of antibody is a potential therapeutic option for the prevention and treatment of C. neoformans. The IgG1 murine monoclonal antibody 2H1 to the capsular polysaccharide of C. neoformans was studied for its ability to modify the course of lethal intracerebral cryptococcal infection in mice. Intraperitoneal administration of antibody 2H1 resulted in small, yet significant, prolongations in the average survival of mice given intracerebral infection and reduced the number of C. neoformans colonies in brain tissue. Histopathological examination of brain tissues revealed a diffuse cryptococcal meningitis with fewer organisms in the brains of mice that received antibody 2H1 than in the control group. Thus, systemic administration of a monoclonal antibody can modify the course of lethal intracerebral C. neoformans infection in mice by prolonging survival and decreasing fungal burden in brain tissues.

Original languageEnglish (US)
Pages (from-to)3636-3640
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume90
Issue number8
DOIs
StatePublished - Apr 15 1993

Keywords

  • Blood-brain barrier
  • Fungus
  • Monoclonal antibody

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection'. Together they form a unique fingerprint.

  • Cite this